TuisCDXC • NASDAQ
add
Chromadex Corp
Vorige sluiting
$7,46
Dagwisseling
$7,15 - $7,75
Jaarwisseling
$1,32 - $7,85
Markkapitalisasie
578,19 m USD
Gemiddelde volume
2,13 m
P/V-verhouding
400,95
Dividend-opbrengs
-
Primêre beurs
NASDAQ
Marknuus
.INX
0,57%
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Inkomste | 25,58 m | 31,21% |
Bedryfskoste | 14,64 m | 11,60% |
Netto inkomste | 1,88 m | 295,83% |
Netto winsgrens | 7,34 | 249,19% |
Wins per aandeel | 0,02 | 300,00% |
EBITDA | 1,80 m | 306,17% |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 32,25 m | 21,13% |
Totale bates | 56,52 m | 5,68% |
Totale aanspreeklikheid | 22,15 m | -15,37% |
Totale ekwiteit | 34,37 m | — |
Uitstaande aandele | 76,55 m | — |
Prys om te bespreek | 16,58 | — |
Opbrengs op bates | 7,24% | — |
Opbrengs op kapitaal | 11,26% | — |
Kontantvloei
Netto kontantverandering
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | 1,88 m | 295,83% |
Kontant van bedrywe | 3,50 m | 782,58% |
Kontant van beleggings | -21,00 k | 19,23% |
Kontant van finansiering | 1,04 m | 34 733,33% |
Netto kontantverandering | 4,51 m | 1 129,70% |
Beskikbare kontantvloei | 3,54 m | 409,89% |
Meer oor
ChromaDex is a dietary supplement and food ingredient company based in Los Angeles, California founded in 1999 that is publicly traded on the NASDAQ.
In 2011, ChromaDex licensed patents from Dartmouth College, Cornell University, and Washington University in St. Louis regarding nicotinamide riboside, which it markets and sells as an ingredient under the brand name Niagen. ChromaDex licensed patents from the University of Mississippi and the USDA to commercially develop pterostilbene and sell the compound under the brand name pTeroPure. ChromaDex no longer sells pTeroPure. Wikipedia
Gestig
1999
Webwerf
Werknemers
106